Clinical Management of Drug Addicts Infected with Human Immunodeficiency Virus and Hepatitis C Virus

References

• United Nations AIDS (UNAIDS). 2006 . Report on the global epidemic of AIDS: Executive Summary , UNAIDS/06–20E English, ISBN 929–1735–116, Joint United Nations Programme on HIV/AIDS/WHO, 2006.
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). 2006 . Overview of Findings from the 2005 National Survey on Drug Abuse and Health , NSDUH Series H-24, DHHS Publications Rockville, MD : Office of Applied Studies .
   Google Scholar
• United Nations AIDS (UNAIDS). 2003 . Report on the global epidemic of AIDS: Executive Summary , UNAIDS/ 03–20E English, ISBN 929–1735–116, Joint United Nations Programme on HIV/AIDS/WHO
   Google Scholar
• Gayle , H. 2000 . An overview of the global HIV/AIDS epidemic, with a focus on the United States . AIDS , 14 ( supplement 2 ) : S8 – S17 .
   Google Scholar
• Gayle , H D and Hill , G L. 2001 . Global impact of human immunodeficiency virus and AIDS . Clin Microbiol Rev , 14 ( 2 ) : 327 – 335 .
   PubMed Web of Science ®Google Scholar
• Sullivan , L E and Fiellin , D A. 2004 . Hepatitis C and HIV in fections: implications for clinical care in injection drug users . Am J Addict , 13 ( 1 ) : 1 – 20 .
   Web of Science ®Google Scholar
• Hammer , G P , Kellogg , T A , McFarland , W C , Wong , E , Louie , B , Williams , I , Dilley , J , Page-Shafer , K and Klausner , J D. 2003 . Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997–2000 . Sex Transm Dis , 30 ( 12 ) : 919 – 24 .
   PubMed Web of Science ®Google Scholar
• Gunn , R A , Murray , P J , Ackers , M L , Hardison , W G and Margolis , H S. 2001 . Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services . Sex Transm Dis , 28 ( 3 ) : 166 – 70 .
   Web of Science ®Google Scholar
• Meandzija , B , O'Connor , P G , Fitzgerald , B , Rounsaville , B J and Kosten , T R. 1994 . HIV infection and cocaine use in methadone maintained and untreated intravenous drug users . Drug Alcohol Dependence , 36 : 109 – 13 .
   PubMed Web of Science ®Google Scholar
• Stark , K , Muller , R , Bienzle , U and Guggenmoos-Holsmann , I. 1996 . Methadone maintenance treatment and HIV risk-taking behavior among injecting drug users in Berlin . J Epidemiol Community Health , 50 : 534 – 7 .
   PubMed Web of Science ®Google Scholar
• Metzger , D S , Woody , G E , McLellan , A T , O'Brien , C P , Druley , P , Navaline , H , DePhilippis , D , Stolley , P and Abrutyn , E. 1993 . Human immunodeficiency virus seroconversion among intravenous drug users in-and out-of-treatment: an 18-month prospective follow-up . J Acquir Immune Defic Syndr , 6 : 1049 – 56 .
   PubMed Web of Science ®Google Scholar
• Moss , A R , Vranizan , K , Gorter , R , Bachetti , P , Watters , J and Osmond , D. 1994 . HIV seroconversion in intravenous drug users in San Francisco, 1985–1990 . AIDS , 8 : 223 – 31 .
   PubMed Web of Science ®Google Scholar
• Soriano , V , Ramos , B , Nunez , M , Barreiro , P , Maida , I , Garcia-Samaniego , J and Gonzalez-Lahoz , J. 2005 . Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype . J Infect Dis , 192 ( 7 ) : 1245 – 8 .
   Web of Science ®Google Scholar
• O'Connor , P G. 2000 . HIV post-exposure therapy for drug users in treatment . J Subst Abuse Treat , 18 : 17 – 21 .
   Google Scholar
• USPHS/Kaiser. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents November 10, 2003. Available at http://www.aidsinfo.nih.gov/gudelines/adult/AA_1.11003.pdf
   Google Scholar
• Lalezari , J P , Henry , K , O'Hearn , M , Montaner , J S , Piliero , P J , Trottier , B , Walmsley , S , Cohen , C , Kuritzkes , D R , Eron , J J Jr , Chung , J , DeMasi , R , Donatacci , L , Drobnes , C , Delehanty , J , Salgo , M and TORO 1 Study Group. 2003 . Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America [comment] . N Engl J Med , 348 : 2175 – 85 .
   PubMed Web of Science ®Google Scholar
• Baxter , J D , Mayers , D L Wentworth , D N . 2000 . A randomized study of antiretroviral management based on plasma genotype antiretroviral resistance testing in patients failing therapy CPCRA 046 Study team for the Terry Beirn Community Programs for Clinical Research on AIDS . AIDS , 14 : f83 – 93 .
   PubMed Web of Science ®Google Scholar
• Pallela , F J , Delaney , K M , Moorman , A C , Loveless , M O , Fuhrer , J , Satten , G A , Aschman , D J and Holmberg , S D. 1998 . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection, HIV Outpatient Study Investigators . N Engl J Med , 338 : 853 – 60 .
   PubMed Web of Science ®Google Scholar
• Hinkin , C , Castellon , S A , Levine , A J , Barclay , T R and Singer , E J. 2008 . Neurocognition in individuals co-infected with HIV and hepatitis C . J Addictive Dis , 27 ( 2 ) : 11 – 7 .
   PubMed Web of Science ®Google Scholar
• O'Connor , P G , Selwyn , P A and Schottenfeld , R S. 1994 . Medical care for injection-drug users with human immunodeficiency virus infection . N Engl J Med , 331 : 450 – 9 .
   PubMed Web of Science ®Google Scholar
• O'Connor , P G , Molde , S , Henry , S , Shockcor , W T and Schottenfeld , R S. 1992 . Human immunodeficiency virus infection in intravenous drug users: a model for primary care . Am J Med , 93 : 382 – 6 .
   PubMed Web of Science ®Google Scholar
• Khalsa , J H , Genser , S , Vocci , F , Francis , H and Bean , P. 2002 . The challenging interactions between antiretroviral agents and addiction drugs . Am Clin Lab , 21 ( 3 ) : 10 – 3 .
   Google Scholar
• McCance-Katz , E F , Rainey , P M , Jatlow , P and Friedland , G. 1998 . Methadone effects on Zidovudine disposition, AIDS Clinical Trials Group 262 . J Acquir Immune Defic Syndr , 18 : 435 – 43 .
   Web of Science ®Google Scholar
• Rainey , P M , Friedland , G , McCance-Katz , E F , Andrews , L , Mitchell , S M , Church , C and Jatlow , P. 2000 . Interaction of methadone with didanosine and stavudine . J Acquir Immun Defic Syndr , 24 : 241 – 8 .
   PubMed Web of Science ®Google Scholar
• Rainey , P M , Friedland , G , Snidow , J W , Mitchell , S M , Andrews , L , Lane , B and Jatlow , P. 2002 . The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiatedependent subjects . Am J Addict , 11 : 66 – 74 .
   PubMed Web of Science ®Google Scholar
• Clarke , S M , Mulcahy , F M , Tija , J , Reynolds , H E , Gibbons , S E , Barry , M G and Back , D J. 2001 . The pharmacokinetic interactions of nevirapine and methadone and guidelines for the use of Nevirapine to treat injection drug users . Clin Infect Dis , 33 : 1595 – 7 .
   PubMed Web of Science ®Google Scholar
• Clarke , S M , Mulcahy , F M , Tija , J , Reynolds , H E , Gibbons , S E , Barry , M G and Back , D J. 2001 . The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz . Br J Clin Pharmacol , 51 : 213 – 7 .
   PubMed Web of Science ®Google Scholar
• Akerele , E O , Levin , F , Nunes , E , Brady , R and Kleber , H. 2002 . Effects of HIV triple therapy on methadone levels . Am J Addict , 11 : 308 – 14 .
   PubMed Web of Science ®Google Scholar
• Carrieri , M P , Vlahov , D , Dellamonica , P , Gallais , H , Lapeu , G , Spire , B , Obadia , Y. and The Manif-2000 Study Group . 2000 . Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART . Drug Alcohol Depend , 60 : 51 – 4 .
   PubMed Web of Science ®Google Scholar
• NIH. National Institutes of Health. 1997 . Management of hepatitis C . NIH Consensus Statement , available at http://odp.odo.nih.gov/consensus/cons/105/105_intro.htm).
   Google Scholar
• NIH. National Institutes of Health . 2002 . Consensus Development Conference Statement, Management of Hepatitis C . Hepatology , 6 ( Suppl 1 ) : s3 – s20 .
   Google Scholar
• Seeff , L B and Hoofnagle , J H. 2003 . The National Institutes of Health Consensus Development Conference Management of Hepatitis C . Clin Liver Dis , 7 ( 1 ) : 261 – 87 .
   PubMedGoogle Scholar
• Strader , D B , Wright , T , Thomas , D L and Seef , L B. 2004 . Diagnosis, management, and treatment of hepatitis C . Hepatology , 39 : 1147 – 71 .
   PubMed Web of Science ®Google Scholar
• Edlin , B R , Kresina , T F , Raymond , D B , Carden , M R , Gourevitch , M N , Rich , J D , Cheever , L W and Cargill , V A. 2005 . Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users . Clin Infect Dis , 40 ( Suppl 5 ) : s276 – s85 .
   PubMed Web of Science ®Google Scholar
• Sylvestre , D L. 2005 . Treatment for hepatitis C virus infection among current injection drug users . Clin Infect Dis , 40 ( Suppl 5 ) : s321 – s4 .
   PubMed Web of Science ®Google Scholar
• Kresina , T F , Khalsa , J , Cesari , H and Francis , H. 2005 . Hepatitis C infection and substance abuse: medical management and developing models of integration . Clin Infect Dis , 40 ( 5 ) : s259 – s62 .
   Google Scholar
• Hall , C S , Charlebois , E D , Hahn , J A , Moss , A R and Bangsberg , D R . 2004 . Hepatitis C virus infection in San Francisco's HIV-infected urban poor . J Gen Intern Med , 19 ( 4 ) : 357 – 65 .
   Web of Science ®Google Scholar
• Thomas , D L and Sulkowski , M S . 2008 . Detection of liver disease in injection drug users . J Addictive Dis , 27 ( 2 ) : 19 – 24 .
   Web of Science ®Google Scholar
• Taylor , L E , Gholam , P M , Schwartzapfel , B and Rich , J D . 2005 . Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report . AIDS Read , 15 ( 11 ) : 629 – 31 . 634–6, 638.
   Google Scholar
• Grebaly , J , deVlaming , S , Duncan , F , Viljoen , M and Conway , B. 2008 . Current approaches to HCV infection in current and former injection drug users . J Addictive Dis , 27 ( 2 ) : 25 – 35 .
   Web of Science ®Google Scholar
• Lozano , J , Polo , L , Gutierrez , E Mora , Martinez , V Perez , Santamaria , J Gutierrez , Vada , S J , Vallejo , J and Correas , A. 1997 . Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection . Rev Clin Esp , 197 ( 7 ) : 479 – 83 .
   Web of Science ®Google Scholar
• Dore , G J and Thomas , D L . 2005 . Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection . Semin Liver Dis , 25 ( 1 ) : 18 – 32 .
   Web of Science ®Google Scholar
• Strauss , S M , Astone , J M , Hagan , H and Des Jarlais , D C. 2004 . The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units . J Urban Health , 81 ( 1 ) : 38 – 47 .
   PubMed Web of Science ®Google Scholar
• Walley , A Y , White , M C , Kushel , M B , Song , Y S and Tulsky , J P . 2005 . Knowledge of and interest in hepatitis C treatment at a methadone clinic . J Subst Abuse Treat , 28 ( 2 ) : 181 – 7 .
   PubMed Web of Science ®Google Scholar
• MacDonald , M. , Law , M. , Kaldor , J M , Hales , J and Dore , G J . 2003 . Effectiveness of needle and syringe programmes for preventing HIV transmission . Int J Drug Policy , 14 : 353 – 7 .
   Google Scholar
• Estrada , A L. 2002 . Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users . Public Health Rep , 117 ( Suppl 1 ) : S126 – 34 .
   Google Scholar
• Garfein , R S , Doherty , M C , Monterroso , E R , Thomas , D L , Nelson , K E and Vlahov , D. 1998 . Prevalence and incidence of hepatitis C virus infection among young adult injection drug users . J Acquir Immune Defic Syndr Hum Retrovirol , 18 ( Suppl 1 ) : 11 – 19 .
   PubMedGoogle Scholar
• Quaglio , G , Lugoboni , F and Pajusco , B. 2003 . Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy . Clin Infect Dis , 37 : 33 – 40 .
   PubMedGoogle Scholar
• MacDonald , M A , Wodak , A D , Dolan , K A , van Beek , I , Cunningham , P H and Kaldor , J M . 2000 . Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995–1997. Collaboration of Australian NSPs . Med J Aust , 172 : 57 – 61 .
   PubMed Web of Science ®Google Scholar
• Thomas , D L , Vlahov , D and Solomon , L. 1995 . Correlates of hepatitis C virus infections among injection drug users . Medicine (Baltimore) , 74 : 212 – 20 .
   PubMed Web of Science ®Google Scholar
• Law , M G. 1999 . Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group . J Gastroenterol Hepatol , 14 : 1100 – 07 .
   PubMedGoogle Scholar
• Dore , G J , Law , M , MacDonald , M and Kaldor , J M . 2003 . Epidemiology of hepatitis C virus infection in Australia . J Clin Virol , 26 ( 2 ) : 171 – 84 .
   PubMed Web of Science ®Google Scholar
• Mayor , A M , Gomez , M A , Fernandez , D M , Rios-Olivares , E , Thomas , J C and Hunter , R F . 2006 . Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection . Am J Trop Med Hyg , 74 ( 2 ) : 239 – 45 .
   Web of Science ®Google Scholar
• Backus , L I , Boothroyd , D and Deyton , L R . 2005 . HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations . AIDS , 19 ( Suppl 3 ) : S13 – 9 .
   PubMed Web of Science ®Google Scholar
• Grassi , L , Satriano , J , Serra , A , Biancosino , B , Zotos , S , Sighinolfi , L and Ghinelli , F. 2002 . Emotional stress, psychosocial variables and coping associated with hepa titis C virus and human immunodeficiency virus infec tions in intravenous drug users . Psychother Psychosom , 71 ( 6 ) : 342 – 9 .
   Web of Science ®Google Scholar
• Ryan , E L , Morgello , S , Isaacs , K , Naseer , M and Gerits , P. 2004 . The Manhattan HIV Brain Bank, Neuropsychiatric impact of hepatitis C on advanced HIV . Neurology , 62 ( 6 ) : 957 – 62 .
   PubMed Web of Science ®Google Scholar
• Rosenberg , S D , Goodman , L A , Osher , F C , Swartz , M S , Essock , S M , Butterfield , M I , Constantine , N T , Wolford , G L and Salyers , M P . 2001 . Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness . Am J Public Health , 91 ( 1 ) : 31 – 7 .
   PubMed Web of Science ®Google Scholar
• Klinkenberg , W D , Caslyn , R J , Morse , G A , Yonker , R D , McCudden , S , Ketema , F and Constantine , N T . 2003 . Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders . Compr Psychiatry , 44 ( 4 ) : 293 – 302 .
   PubMed Web of Science ®Google Scholar
• Baum , M , Jayaweera , D T , Rui , D , Sales , S , Lai , S , Rafie , C , Regev , A , Page , J B , Berkman , R and Campa , A. 2008 . Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami . J Addictive Dis , 27 ( 2 ) : 37 – 48 .
   PubMed Web of Science ®Google Scholar
• Monto , A , Currie , S and Wright , T L . 2008 . Liver disease in injection drug users with hepatitis C, with and without HIV co-infection . J Addictive Dis , 27 ( 2 ) : 49 – 59 .
   PubMed Web of Science ®Google Scholar
• Kresina , T F , Flexner , C W , Sinclair , J , Correia , M A , Stapleton , J T , Adeniyi-Jones , S , Cargill , V and Cheever , L W . 2002 . Alcohol use and HIV pharmacotherapy . AIDS Res Hum Retroviruses , 18 ( 11 ) : 757 – 70 .
   PubMed Web of Science ®Google Scholar
• Cooper , C. 2008 . Obstacles to successful HCV treatment in substance addicted patients . J Addictive Dis , 27 ( 2 ) : 61 – 8 .
   Web of Science ®Google Scholar
• Di Martino , V , Rufat , P , Boyer , N , Renard , P , Degos , F , Martinot-Peignoux , M , Matheron , S , Le , M V , Vachon , F , Degott , C , Valla , D and Marcellin , P. 2001 . The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study . Hepatology , 34 ( 6 ) : 1193 – 9 .
   PubMed Web of Science ®Google Scholar
• Serfaty , L , Costagliola , D , Wendum , D , Picard , O , Meyohas , M C , Girard , P M , Lebas , J , Delamare , C , Poupon , R and Housset , C. 2001 . Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study . AIDS , 15 ( 15 ) : 2011 – 6 .
   Web of Science ®Google Scholar
• Di Martino , V , Thevenot , T , Boyer , N , Cazals-Hatem , D , Degott , C , Valla , D and Marcellin , P. 2002 . HIV co-infection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C . AIDS , 16 ( 3 ) : 441 – 5 .
   PubMed Web of Science ®Google Scholar
• McGovern , B. 2008 . A golden opportunity: the treatment of hepatitis C in HIV-infected inmates . J Addictive Dis , 27 ( 2 ) : 69 – 73 .
   Web of Science ®Google Scholar
• Balasubramanian , A , Groopman , J E and Ganju , R K . 2008 . Underlying pathophysiology of HCV infection in HIV-positive drug users . J. Addictive Dis , 27 ( 2 ) : 75 – 82 .
   Web of Science ®Google Scholar
• Blackard , J T , Koumurian-Pradel , F , Perret , M , Sodoyer , M , Smeaton , L , Clair , J B , Chapman , S , Taylor , L E , Paranhos-Baccala , G and Chung , R T . 2006 . Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection . J Med Virol. , 78 : 202 – 7 .
   Google Scholar
• Carlos , M J , Castilla , J , Lopez , M , Arranz , R , Gonzalez-Lahoz , J and Soriano , V. 2004 . Impact of chronic hepatitis C on HIV-1 disease progression . HIV Clin Trials , 5 ( 3 ) : 125 – 31 .
   Web of Science ®Google Scholar
• Soriano , V , Garcia-Samaniego , J , Valencia , E , Rodriguez-Rosado , R , Munoz , F and Gonzalez-Lahoz , J. 1999 . Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users . Eur J Epidemiol , 15 ( 1 ) : 1 – 4 .
   PubMed Web of Science ®Google Scholar
• Klein , M B , Lalonde , R G and Suissa , S. 2003 . The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy . J Acquir Immune Defic Syndr , 33 ( 3 ) : 365 – 72 .
   PubMed Web of Science ®Google Scholar
• Tedaldi , E M. 2008 . Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies . J. Addictive Dis , 27 ( 2 ) : 83 – 90 .
   Web of Science ®Google Scholar